Skip to main content

Publications

featured publications

  • Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study.

    Therapeutic advances in hematology

    Authors: Carmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, Ana R Cid, Kate Khair, Johannes Oldenburg, Claude Négrier, Jaco Botha, Aurelia Lelli, Jerzy Windyga

  • Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

    European journal of haematology

    Authors: Mary Mathias, Aby Abraham, Mark J Belletrutti, Manuel Carcao, Manuela Carvalho, Hervé Chambost, Anthony K C Chan, Leonid Dubey, Jonathan Ducore, Michael Gattens, Paolo Gresele, Yves Gruel, Benoit Guillet, Victor Jiménez-Yuste, Lidija Kitanovski, Anna Klukowska, Sunil Lohade, Maria Elisa Mancuso, Johannes Oldenburg, Berardino Pollio, Marianne Sigaud, Kateryna Vilchevska, John K M Wu, Martina Jansen, Larisa Belyanskaya, Olaf Walter, Sigurd Knaub, Ellis J Neufeld

  • Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.

    Advances in therapy

    Authors: Eva Funding, Gillian Lowe, Lone H Poulsen, Susan Shapiro, Johannes Oldenburg, Daniel Eriksson, Aletta Falk, Carly Rich

  • Design of a Real-World Observational Study in Previously Untreated and Minimally Treated Hemophilia A Patients: Protect-NOW.

    TH open : companion journal to thrombosis and haemostasis

    Authors: Johannes Oldenburg, Susan Halimeh, Georgina W Hall, Robert Klamroth, Pascual Marco Vera, Martina Jansen, Mary Mathias

  • Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII.

    Journal of thrombosis and haemostasis : JTH

    Authors: Behnaz Pezeshkpoor, Nadja Sereda, Ann-Cristin Berkemeier, Isabell Matuschek, Nadine Schwarz, Peter L Turecek, Silvia Horneff, Claudia Klein, Georg Goldmann, Natascha Marquardt, Thilo Albert, Jens Müller, Johannes Oldenburg

  • Osteoporosis Remains Constant in Patients with Hemophilia-Long-Term Course in Consideration of Comorbidities.

    Hamostaseologie

    Authors: Anna C Strauss, Pius Muellejans, Sebastian Koob, Georg Goldmann, Peter H Pennekamp, Thomas A Wallny, Johannes Oldenburg, Andreas C Strauss

  • Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

    Blood advances

    Authors: Amy D Shapiro, Roshni Daniel Kulkarni, Margaret V Ragni, Herve Chambost, Johnny N Mahlangu, Johannes Oldenburg, Beatrice Nolan, Margareth C Ozelo, Meredith C Foster, Annemieke Willemze, Chris Barnowski, Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, K John Pasi

  • Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.

    The New England journal of medicine

    Authors: Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth C Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S Key, Michael Laffan, Amy L Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Joshua Henshaw, Tara M Robinson, Wing Yen Wong, Steven W Pipe

  • HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56bright NK Cells via Stimulation of Monocytes.

    The Journal of infectious diseases

    Authors: Michael ToVinh, Gregor Hörr, Christoph Hoffmeister, Kristiyana Dobrikova, Christina Gotter, Jan Raabe, Kim M Kaiser, Sarah Ahmad, Claudia Finnemann, Eyleen Matejec, Gudrun Hack, Jenny Bischoff, Gereon J Rieke, Carolynne Schwarze-Zander, Christoph Boesecke, Kathrin van Bremen, Jan-Christian Wasmuth, Anna M Eis-Hübinger, Hendrik Streeck, Hedda L Verhasselt, Johannes Oldenburg, Christian P Strassburg, Jürgen K Rockstroh, Ulrich Spengler, Benjamin Krämer, Jacob Nattermann

  • Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.

    The Lancet. Haematology

    Authors: Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Ronald J Bernardi, Víctor Jiménez-Yuste, Benjamin M Beckermann, Christophe Schmitt, Giuliana Ventriglia, Jerzy Windyga, Roseline d'Oiron, Paul Moorehead, Sunita Koparkar, Vanda Teodoro, Amy D Shapiro, Johannes Oldenburg, Cedric Hermans